4
Changes in Ownership
CAPRICOR THERAPEUTICS, INC. Filed Acc 0001593087-26-000005
CHIEF FINANCIAL OFFICER sold 25,000 shares at $30.13 ($753,153)
- CHIEF FINANCIAL OFFICER acquired 25,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bergmann Anthony CHIEF FINANCIAL OFFICER | 2026-03-31 | Option exercise 10b5-1 | +25,000 | $3.18 | $79,500 | 33,223 | D: show line 1 in the form |
| Bergmann Anthony CHIEF FINANCIAL OFFICER | 2026-03-31 | Sale 10b5-1 | −25,000 | $30.13 | $753,153 | 8,223 | D: show line 2 in the form |
| Open-market sales · 25,000 sh · avg $30.13 · $753,153 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bergmann Anthony CHIEF FINANCIAL OFFICER | 2026-03-31 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 141,980 | D: show line 3 in the form |
Loading xslF345X06/form4-04012026_080406.xml…